Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Severity and mortality of COVID 19 in patients with diabetes, hypertension and cardiovascular disease: a meta-analysis
Bianca de Almeida-Pititto, Patrícia Médici Dualib, Lenita Zajdenverg, et al.
Diabetology & Metabolic Syndrome (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 351

Showing 1-25 of 351 citing articles:

Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19
Felice D’Agnillo, Kathie‐Anne Walters, Yongli Xiao, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 620
Open Access | Times Cited: 191
Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: a systematic review and meta-analysis of observational studies
Yahya Mahamat‐Saleh, Thibault Fiolet, Mathieu E. Rebeaud, et al.
BMJ Open (2021) Vol. 11, Iss. 10, pp. e052777-e052777
Open Access | Times Cited: 164
COVID-19 y diabetes mellitus: una relación bidireccional
Marcos M. Lima-Martínez, Carlos Boada, Marialaura D. Madera-Silva, et al.
Clínica e Investigación en Arteriosclerosis (2020) Vol. 33, Iss. 3, pp. 151-157
Open Access | Times Cited: 154
Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence
Marina Treskova, Laura Haas, Sarah Reda, et al.
BMC Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 152
Umbilical Cord Mesenchymal Stromal Cells as Critical COVID-19 Adjuvant Therapy: A Randomized Controlled Trial
Ismail Hadisoebroto Dilogo, Dita Aditianingsih, Adhrie Sugiarto, et al.
Stem Cells Translational Medicine (2021) Vol. 10, Iss. 9, pp. 1279-1287
Open Access | Times Cited: 139
COVID–19 and chronic kidney disease: an updated overview of reviews
Sara S. Jdiaa, Razan Mansour, Abdallah El Alayli, et al.
Journal of Nephrology (2022) Vol. 35, Iss. 1, pp. 69-85
Open Access | Times Cited: 121
Covid-19 and non-communicable diseases: evidence from a systematic literature review
Zlatko Nikoloski, Ada Alqunaibet, Rasha Abdulrahman Alfawaz, et al.
BMC Public Health (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 116
Epidemiology, risk factors and prognosis of cardiovascular disease in the Coronavirus Disease 2019 (COVID-19) pandemic era: a systematic review
Garyfallia Pepera, Marina-Sofia Tribali, Ladislav Baťalík, et al.
Reviews in Cardiovascular Medicine (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 69
Global prevalence and effect of comorbidities and smoking status on severity and mortality of COVID-19 in association with age and gender: a systematic review, meta-analysis and meta-regression
Santenna Chenchula, Kota Vidyasagar, Saman Pathan, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 41
COVID-19 and diabetes: A bidirectional relationship
Marcos M. Lima-Martínez, Carlos Boada, Marialaura D. Madera-Silva, et al.
Clínica e Investigación en Arteriosclerosis (English Edition) (2021) Vol. 33, Iss. 3, pp. 151-157
Closed Access | Times Cited: 97
A Bittersweet Response to Infection in Diabetes; Targeting Neutrophils to Modify Inflammation and Improve Host Immunity
Rebecca Dowey, Ahmed Iqbal, Simon Heller, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 68
Heparin prevents in vitro glycocalyx shedding induced by plasma from COVID-19 patients
Simone R. Potje, Tiago J. Costa, Thais Fernanda de Campos Fraga‐Silva, et al.
Life Sciences (2021) Vol. 276, pp. 119376-119376
Open Access | Times Cited: 61
Why Is COVID-19 More Severe in Patients With Diabetes? The Role of Angiotensin-Converting Enzyme 2, Endothelial Dysfunction and the Immunoinflammatory System
Jacob Roberts, Antonia L. Pritchard, Andrew T. Treweeke, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 7
Open Access | Times Cited: 60
Hypertension and COVID-19: Ongoing Controversies
Marijana Tadić, Sahrai Saeed, Guıdo Grassı, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 57
Universal healthcare as pandemic preparedness: The lives and costs that could have been saved during the COVID-19 pandemic
Alison P. Galvani, Alyssa S. Parpia, Abhishek Pandey, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 25
Open Access | Times Cited: 54
Therapeutic monoclonal antibodies for COVID-19 management: an update
Vivek P. Chavda, Riddhi Prajapati, Disha Lathigara, et al.
Expert Opinion on Biological Therapy (2022) Vol. 22, Iss. 6, pp. 763-780
Closed Access | Times Cited: 51
The Impact of COVID-19 on Individuals Across the Spectrum of Visual Impairment
Wesam Shamseldin Shalaby, Annamalai Odayappan, Rengaraj Venkatesh, et al.
American Journal of Ophthalmology (2021) Vol. 227, pp. 53-65
Open Access | Times Cited: 53
Diabetes and the Risk of Long-term Post-COVID Symptoms
César Fernández‐de‐las‐Peñas, Carlos Guijarro, Juan Torres‐Macho, et al.
Diabetes (2021) Vol. 70, Iss. 12, pp. 2917-2921
Open Access | Times Cited: 53
ACC Health Policy Statement on Cardiovascular Disease Considerations for COVID-19 Vaccine Prioritization
Elissa Driggin, Thomas M. Maddox, Keith C. Ferdinand, et al.
Journal of the American College of Cardiology (2021) Vol. 77, Iss. 15, pp. 1938-1948
Open Access | Times Cited: 47
COVID-19: Immunology, Immunopathogenesis and Potential Therapies
Asha Bhardwaj, Leena Sapra, Chaman Saini, et al.
International Reviews of Immunology (2021) Vol. 41, Iss. 2, pp. 171-206
Open Access | Times Cited: 47
An Update on COVID-19 Related Ophthalmic Manifestations
Kristina Jevnikar, Polona Jaki Mekjavić, Nataša Vidović Valentinčič, et al.
Ocular Immunology and Inflammation (2021) Vol. 29, Iss. 4, pp. 684-689
Closed Access | Times Cited: 43
Type 2 Diabetes Mellitus and COVID-19: A Narrative Review
Cristina Rey‐Reñones, Sara Martínez-Torres, Francisco Martín‐Luján, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2089-2089
Open Access | Times Cited: 30
The impact of pre-existing hypertension and its treatment on outcomes in patients admitted to hospital with COVID-19
Ewan McFarlane, Marijke Linschoten, Folkert W. Asselbergs, et al.
Hypertension Research (2022) Vol. 45, Iss. 5, pp. 834-845
Open Access | Times Cited: 29
COVID-19 as a Risk Factor for Alzheimer’s Disease
Mahdieh Golzari-Sorkheh, Donald F. Weaver, Mark A. Reed
Journal of Alzheimer s Disease (2022) Vol. 91, Iss. 1, pp. 1-23
Open Access | Times Cited: 27
The Impact of Comorbidities and Obesity on the Severity and Outcome of COVID-19 in Hospitalized Patients—A Retrospective Study in a Hungarian Hospital
Éva Nagy, Viktória Cseh, István Barcs, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 2, pp. 1372-1372
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top